LAB - Standard BioTools Operating income before deduction of amortization

Public company logo of fluidigm.com (LAB)

Following the merger with IsoPlexis, the updated management of Standard BioTools Inc. (LAB) has effectively optimized expenses, which is reflected in the absolute EBITDA trend, where the parameter value equals 0.00. Profit growth is driven by demand in precision medicine and platform synergies. Development is based on the creation of precision equipment for spatial biology and the refinement of microfluidic systems.

Profit before payment of interest, taxes and amortization: Standard BioTools Inc. (LAB) for 11/23/2025 - 11/10/2026

Standard BioTools (LAB) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Market Chart Standard BioTools Corp|LAB - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Standard BioTools|LAB - Total Company Value
- balance sheet equity data:
Net Assets per Share Standard BioTools|LAB - Company Book Value|Market Capitalization to Book Value fluidigm.com|LAB - Cumulative Company Assets
- debt level and financial liquidity data:
Aggregate Debt to Capital Standard BioTools Inc.|LAB - Long-Term Debt to Capital|Short-Term Debt to Capital Standard BioTools Inc|LAB - Company Debts|Debt to Book Value Ratio Standard BioTools|LAB - Company Long-Term Debts|Company Short-Term Indebtedness Standard BioTools|Quick Ratio fluidigm.com
- company profitability and valuation multiples indicators:
LAB - Company Net Income|Expected Net Income Standard BioTools Inc.|LAB - P/E Multiple|Price to Future Earnings Ratio fluidigm.com|LAB - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Standard BioTools|LAB - Operating profit EBITDA|Earnings per share for the last twelve months Standard BioTools|LAB - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months fluidigm.com|LAB - Earnings per share growth in current year|Expected net earnings per share growth next year Standard BioTools Inc.
Analysis of all company metrics:Standard BioTools Corp - LAB
Product sample of Standard BioTools

Absolute operating profit measures the cash flow from core operations before depreciation and interest. Monitoring operating profit in cash terms allows for an assessment of the business's real ability to generate cash during a recession. This metric discounts cost management efficiency relative to revenue. For Standard BioTools (LAB), this reflects a dependence on government grants and the R&D budgets of pharma behemoths. The stability of this indicator confirms the technological leadership of the equipment in precision medicine.

Who Standard BioTools Inc. competes with

Operating income before deduction of amortization Agilent Corp (A)|Quest Diagnostics - Operating profit EBITDA|Operating income before deduction of amortization illumina.com ILMN|Exact Sciences Corporation (EXAS) - Profit before payment of interest, taxes and amortization|RVTY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Operating income before deduction of amortization|Operating profit before deduction of amortization SHC (Sotera Health Company)|Company profit before taxes, interest and amortization QDEL|Operating profit EBITDA OPK (OPKO Health)|Operating profit EBITDA CareDx Corp CDNA|MRVI - Profit before payment of interest, taxes and amortization|FLGT (Fulgent) - Operating profit before amortization|CTKB: Operating profit EBITDA|Operating profit before amortization OSUR|XGN (Exagen Inc) - Operating profit EBITDA|Operating profit EBITDA MDxHealth S.A.|Profit before payment of interest, taxes and amortization Lucid Diagnostics Inc (LUCD)|PRE (prenetics.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA IMDX (Insight Molecular Diagnostics Inc)|TRIB: Operating profit before amortization|PRPH: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AIMD (Ainos Inc)|CODX: Operating profit EBITDA|HSCS (Heart Test Labs) - Profit before payment of interest, taxes and amortization|BMRA (Biomerica, Inc.) - Operating profit EBITDA|Cardio Diagnostics Holdings, Inc. (CDIO) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Onconetix (ONCO)|VRAX - Profit before interest, taxes and amortization|Bluejay - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization AWH (Aspira Women's Health Inc)|AXDX - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Centogene|enzo.com (ENZ) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Fresh2 Group (FRES)|Profit before payment of interest, taxes and amortization Genetic Technologies Ltd|Profit before payment of interest, taxes and amortization ME|Profit before payment of interest, taxes and amortization Psychemedics (PMD)